Company Filing History:
Years Active: 2013-2019
Title: The Innovative Mind of Patrick A. Singleton
Introduction
Patrick A. Singleton is a notable inventor based in Chicago, Illinois. With a remarkable portfolio of 9 patents, his work is primarily focused on advancements in medical treatments that target cellular proliferation and migration, particularly in relation to cancer therapies.
Latest Patents
Singleton's latest patents showcase his dedication to innovative therapeutic methods. One of these patents involves the treatment of disorders characterized by cellular proliferation and migration through the co-administration of an mTOR inhibitor and a μ-opioid receptor antagonist. This invention aims to develop effective methods to treat various diseases associated with abnormal cell growth. Another significant patent emphasizes the use of opioid antagonists to attenuate or inhibit endothelial cell proliferation and migration, specifically targeting angiogenesis, tumor growth, and metastasis in cancer. These inventions highlight his commitment to addressing critical health issues through scientific innovation.
Career Highlights
Patrick A. Singleton is currently affiliated with the University of Chicago, where he leverages his expertise in medical research. His contributions to the field are evident in the multiple patents he holds, which reflect his innovative approach to tackling complex medical challenges.
Collaborations
Throughout his career, Singleton has collaborated with other distinguished researchers including Jonathan Moss and Mark Lingen. These partnerships have not only enhanced his work but have also fostered an environment of innovation and progress within the research community.
Conclusion
Patrick A. Singleton's contributions to medical science through his inventions and patents significantly impact the field of treatment for cellular disorders. His innovative spirit and collaborative efforts stand as a testament to the transformative power of research and development in healthcare.